The Seventh Annual US-China High-Level Consultation on People-to-People Exchange was held in Beijing

News provided by

West China Hospital of Sichuan University

Jul 07, 2016, 10:00 ET

CHENGDU, China, July 7, 2016 /PRNewswire/ -- The seventh annual US-China High-Level Consultation on People-to-People Exchange (CPE) was recently held in Beijing. Over 200 representatives from CPE members of both sides and other participating organizations attended the meeting. The consultation between both sides covered the fields of education, science & technology, culture, health, sports, and women. Different programs implemented in the CPE framework were concluded and planned.

Prof. Li Weimin, President of West China Hospital and Gianluca Pettiti, Thermo Fisher Scientific country President of China, unveiled the nameplate for the laboratory

Among the 135 topics for which common understandings have been reached during this round of consultation, 6 representative ones were chosen to be included in the signing ceremony, and the joint precision medical platform built together by West China Hospital, Sichuan University and Thermo Fisher Scientific was one of them. This signature agreement is regarded as a part of cooperation and exchange activities between China and the US, which will help promote the development of precision medicine and pathological studies in western China and benefit the public.

In the morning of June 6, Li Weimin, President of West China Hospital, Sichuan University and Gianluca Pettiti, Thermo Fisher Scientific country president of China, signed a cooperation memorandum for building the joint precision medical research platform in Beijing Westin Hotel. West China Hospital, Sichuan University and Thermo Fisher Scientific will cooperate comprehensively in a number of fields and make joint efforts to create a world leading molecular diagnosis center for the hospital. The specific cooperation programs include building a joint modern clinical pathological laboratory, establishing a hospital-industry cooperative platform for promoting tissue bank, proteomics, molecular diagnosis, and pathological quality control, creating a professional and modern pathological diagnostician training center, and setting up efficient, safe, and integrated business flows.

It is reported that as early as December 1, 2015, the joint modern clinical pathological laboratory built by West China Hospital, Sichuan University and Thermo Fisher Scientific was unveiled. In addition to serving scientists and postgraduate students from hospitals and scientific research organizations affiliated to Sichuan University, it will provide scientific research services for the public.

According to President Li Weimin, West China Hospital, Sichuan University is seeking close cooperation with leading scientific & technical enterprises across the globe to reinforce its advantages in pathology. Cooperation with Thermo Fisher Scientific is expected to improve quality of pathological study and clinical diagnosis. Such cooperation will continue to expand to accelerate development of precision pathological diagnosis in western China and to benefit health of the public.

Photo - http://photos.prnewswire.com/prnh/20160706/386977.

SOURCE West China Hospital of Sichuan University